inactivated vaccines

AstraZeneca Says Its COVID-19 Vaccine Candidate Has 90% Efficacy

COVID-19: Oxford Vaccine Produces Immune Response in Early-Stage Clinical Trial

Explained: How the COVID-19 Vaccine Candidates on the Horizon Work